Predictors of outcome in pleomorphic xanthoastrocytoma.
Antonio DonoVictor Lopez-RiveraAnkush ChandraCole T LewisRania AbdelkhaleqSunil A ShethLeomar Y BallesterYoshua EsquenaziPublished in: Neuro-oncology practice (2020)
In PXA, older age and larger tumor size at diagnosis are risk factors for poor OS, while pediatric patients have remarkably improved survival. Postoperative RT and CT appear to be ineffective treatment strategies while achieving GTR confer an improved survival in male patients and remains the cornerstone of treatment. These findings can help optimize PXA treatment while minimizing side effects. However, further studies of PXAs with molecular characterization are needed.